A lawsuit has been filed over alleged cancer risks associated with the drug Dupixent, specifically a diagnosis of cutaneous T-cell lymphoma (CTCL). The lawsuit claims that side effects of Dupixent led to the CTCL diagnosis, with reported symptoms including enlarged lymph nodes. The lawsuit's details, including any potential settlement, are being investigated and reported on by various outlets.